Human-centered Injury Thrivorship Pathway for Survivors of Physical Trauma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
About this trial
The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is:
• Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors?
Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.
Eligibility criteria
Qualifiers
Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
Admitted to the hospital ≥ 24 hours
Discharged from the hospital alive
San Francisco resident or unhoused in San Francisco
Disqualifiers
Patient < 18 years old
Deceased during index hospitalization
Unable to provide informed consent
Trial design
Treatments tested in this trial
- Human-Centered Injury Thrivorship Pathway
Treatment groups
25 Participants
are divided into 1 treatment groupLocations
1Zuckerberg San Francisco General Hospital94110, San FranciscoCalifornia, United States
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator
Source ClinicalTrials.gov